Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Similar articles for PubMed (Select 23610780)

1.

Author's reply: To PMID 22443211.

Silvestris N, Brunetti AE, Guarini A, Del Re M, Danesi R, Cinieri S.

Expert Opin Ther Targets. 2013 Apr;17(4):474-5. No abstract available.

PMID:
23610780
2.

Comment and reply on: pegfilgrastim is safe and effective in the prevention of neutropenia and treatment delays in biweekly regimens.

Santini D, Frezza AM, Venditti O, Intagliata S, dell'Aquila E, Guida F, Vincenzi B, Tonini G.

Expert Opin Ther Targets. 2013 Apr;17(4):473-4. doi: 10.1517/14728222.2013.773269. Epub 2013 Feb 28. No abstract available.

PMID:
23445337
3.

Prevention of febrile neutropenia: use of granulocyte colony-stimulating factors.

Kelly S, Wheatley D.

Br J Cancer. 2009 Sep;101 Suppl 1:S6-10. doi: 10.1038/sj.bjc.6605269.

4.

Study inclusion criteria and presentation of results in a meta-analysis of granulocyte colony-stimulating factor for prevention of febrile neutropenia.

Lathia N, Isogai PK, Cheung MC, Mittmann N.

J Clin Oncol. 2010 Dec 20;28(36):e762-3; author reply e764. doi: 10.1200/JCO.2010.30.4659. Epub 2010 Nov 15. No abstract available.

5.

Colony-stimulating factors for febrile neutropenia.

Carton E, Bellesoeur A, Mir O.

N Engl J Med. 2013 Jul 18;369(3):285-6. doi: 10.1056/NEJMc1306109#SA4. No abstract available.

PMID:
23863066
6.

Colony-stimulating factors for febrile neutropenia.

Buti S, Sikokis A, Ardizzoni A.

N Engl J Med. 2013 Jul 18;369(3):285. doi: 10.1056/NEJMc1306109#SA3. No abstract available.

PMID:
23863065
7.

Colony-stimulating factors for febrile neutropenia.

Kelly C, O'Mahony D, O'Reilly S.

N Engl J Med. 2013 Jul 18;369(3):284-5. doi: 10.1056/NEJMc1306109#SA2. No abstract available.

PMID:
23863064
8.

Colony-stimulating factors for febrile neutropenia.

Ishiguro H, Toi M.

N Engl J Med. 2013 Jul 18;369(3):284. doi: 10.1056/NEJMc1306109#SA1. No abstract available.

PMID:
23863063
9.

Colony-stimulating factors for febrile neutropenia.

Djulbegovic B, Norris LB, Bennett CL.

N Engl J Med. 2013 Jul 18;369(3):286. doi: 10.1056/NEJMc1306109. No abstract available.

10.

Colony-stimulating factors in the prevention of solid tumors induced by chemotherapy in patients with febrile neutropenia.

Freyer G, Ligneau B, Trillet-Lenoir V.

Int J Antimicrob Agents. 1998 Apr;10(1):3-9. Review.

PMID:
9624538
11.

Clozapine and granulocyte colony-stimulating factor: potential for long-term combination treatment for clozapine-induced neutropenia.

Mathewson KA, Lindenmayer JP.

J Clin Psychopharmacol. 2007 Dec;27(6):714-5. No abstract available.

PMID:
18004146
12.

Colony-stimulating factors stimulate some treatments, continue to evolve.

Volkers N.

J Natl Cancer Inst. 1999 Feb 3;91(3):210-2. No abstract available.

13.

When the risk of febrile neutropenia is 20%, prophylactic colony-stimulating factor use is clinically effective, but is it cost-effective?

Adams JR, Angelotta C, Bennett CL.

J Clin Oncol. 2006 Jul 1;24(19):2975-7. Epub 2006 May 8. No abstract available.

14.
15.

Chemotherapy and granulocyte colony-stimulating factor in ovarian cancer.

Ochiai K, Terashima Y.

Semin Oncol. 1994 Feb;21(1 Suppl 1):23-8. No abstract available.

PMID:
7512275
17.

Meta-analysis of randomized controlled trials of granulocyte colony-stimulating factor prophylaxis in adult cancer patients receiving chemotherapy.

Kuderer NM.

Cancer Treat Res. 2011;157:127-43. doi: 10.1007/978-1-4419-7073-2_8. No abstract available.

PMID:
21052954
18.

[Guidelines for prevention of febrile neutropenia].

Barroso S, Damasceno M, Dinis J, Gervásio H, da Luz R, Passos-Coelho JL, Sá A, Costa L, Rodrigues H, Andrade S, Macedo A, Moital I.

Acta Med Port. 2008 Jan-Feb;21(1):7-19. Epub 2008 Apr 18. Review. Portuguese.

19.

Granulocyte and granulocyte-macrophage colony-stimulating factors.

Steward WP.

Lancet. 1993 Jul 17;342(8864):153-7. Review. No abstract available.

PMID:
7687319
20.

Granulocyte colony-stimulating factor in children with acute lymphoblastic leukemia.

Welte K, Riehm H.

N Engl J Med. 1997 Oct 30;337(18):1320; author reply 1321. No abstract available.

PMID:
9380088
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk